Study on drug resistance of Pseudomonas aeruginosa plasmid-mediated AmpC β-lactamase

Zhu,Bin; Zhang,Ping; Huang,Zhen; Yan,Hai-Qing; Wu,An‑Hua; Zhang,Gang-Wen; Mao,Qianguo

doi:10.3892/mmr.2012.1235

Study on drug resistance of Pseudomonas aeruginosa plasmid-mediated AmpC β-lactamase

Authors:
- Bin Zhu
- Ping Zhang
- Zhen Huang
- Hai-Qing Yan
- An‑Hua Wu
- Gang-Wen Zhang
- Qianguo Mao
View Affiliations

Affiliations: Department of Infectious Disease, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, P.R. China, Department of Infectious Disease, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, P.R. China, Center of Infectious Control, Xiangya Hospital Center South University, Xiangya 410008, P.R. China, Department of Hepatology, Xiamen Traditional Chinese Medicine Hospital, Xiamen 361004, P.R. China
Published online on: December 14, 2012 https://doi.org/10.3892/mmr.2012.1235
Pages: 664-668

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the resistance of plasmid-mediated AmpC β-lactamase in Pseudomonas aeruginosa, to detect and identify the AmpC genotype and to provide evidence for antibiotic applications in the clinic. Resistance phenotype in 108 strains of clinically isolated P. aeruginosa was determined by Kirby-Bauer disk test and cefoxitin three dimensional test in AmpC-positive strains. Plasmids were extracted from AmpC-positive strains using the SDS-alkali splitting technique. The depurated plasmid was used to amplify AmpC β-lactamase genes by PCR. Positive PCR products were sequenced by the Shanghai Sangon Biological Engineering Technology Company. Gene homology of PCR products with other index sample gene sequences was compared. In the present study, 28 AmpC enzyme-positive P. aeruginosa strains among 108 were identified. Multidrug‑resistance to antibiotics was observed in positive AmpC P. aeruginosa strains and a new P. aeruginosa strain of plasmid-mediated CMY-7 type AmpC enzyme was identified. In addition, AmpC type β-lactamases were revealed to be important in the resistance mechanism to antibiotics in P. aeruginosa. This is the first report of CMY-7 plasmid‑mediated AmpC enzyme expression in P. aeruginosa.

View Figures

View References

1	Lister PD, Wolter DJ and Hanson ND: Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 22:582–610. 2009.PubMed/NCBI
2	Yong D, Toleman MA, Giske CG, et al: Characterization of a new metallo-lactamase gene, bla NDM-1 and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 53:5046–5054. 2009. View Article : Google Scholar : PubMed/NCBI
3	Papanicolaou GA, Medeiros AA and Jacoby GA: Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 34:2200–2209. 1990. View Article : Google Scholar : PubMed/NCBI
4	Driscoll JA, Brody SL and Kollef MH: The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs. 67:351–368. 2007. View Article : Google Scholar : PubMed/NCBI
5	Obritsch MD, Fish DN, MacLaren R and Jung R: National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother. 48:4606–4610. 2004.PubMed/NCBI
6	Zhanel GG, DeCobry M, Adam H, et al: Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob Agents Chemother. 54:4684–4693. 2010. View Article : Google Scholar : PubMed/NCBI
7	Weldhagen GF, Poirel L and Nordmann P: Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother. 47:2385–2392. 2003. View Article : Google Scholar : PubMed/NCBI
8	Moyá B, Zamorano L, Juan C, Ge Y and Oliver A: Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 54:3933–3937. 2010.PubMed/NCBI
9	Burmolle M, Thomsen TR, Fazli M, et al: Biofilmsin chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol. 59:324–336. 2010.PubMed/NCBI
10	del Pozo JL and Patel R: The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther. 82:204–209. 2007.PubMed/NCBI
11	Pfeifer Y, Cullik A and Witte W: Resistance to cephalosporins and carbapenems in gram-negative bacterial pathogens. Int J Med Microbiol. 300:371–379. 2010. View Article : Google Scholar : PubMed/NCBI
12	Nikaido H: Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 33:1831–1836. 1989. View Article : Google Scholar : PubMed/NCBI
13	Wikler MA, Cockerill FR, Craig WA, et al: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 7th edition. Clinical and Laboratory Standards Institute; Wayne, PA: 2006
14	Vincent JL: Nosocomial infections in adult intensive care units. Lancet. 361:2068–2077. 2003. View Article : Google Scholar : PubMed/NCBI
15	Carmeli Y, Troillet N, Eliopoulos GM and Samore MS: Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risk associated with different antipseudomonal agents. Antimicrob Agents Chemother. 43:1379–1382. 1999.PubMed/NCBI
16	Cavallo JD, Fabre R, Leblanc F, Nicolas-Chanoine MH and Thabaut A: Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a French multicentre study (1996). J Antimicrob Chemother. 46:133–136. 2000. View Article : Google Scholar : PubMed/NCBI
17	Livermore DM: Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 34:634–640. 2002. View Article : Google Scholar : PubMed/NCBI
18	Thomson KS: Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis. 7:333–336. 2001. View Article : Google Scholar : PubMed/NCBI
19	Tan TY, Ng LS, He J, Koh TH and Hsu LY: Evaluation of screening methods to detect plasmid mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Antimicrob Agents Chemother. 53:146–149. 2009. View Article : Google Scholar : PubMed/NCBI
20	Abdalhamid B, Wickman PA and Hanson ND: Correlation of ampC induction with PBP binding in Enterobacter cloacae. In: 45th Intersci Conf Antimicrob Agents Chemother; Washington DC. pp. C1–2211. 2005
21	Kuga A, Okamoto R and Inoue M: AmpR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae. Antimicrob Agents Chemother. 44:561–567. 2000. View Article : Google Scholar : PubMed/NCBI
22	Pfeifer Y, Cullik A and Witte W: Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 300:371–379. 2010. View Article : Google Scholar : PubMed/NCBI
23	Shahid M, Malik A and Sheeba: Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett. 228:181–186. 2003.
24	Lee SH, Kim JY, Shin SH, et al: Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamases genes among clinical isolates of Enterobacter Species in Korea. J Clin Microbiol. 41:2477–2482. 2003. View Article : Google Scholar : PubMed/NCBI